Alzheimer's disease

Alzheimer's researchers link glucose metabolism to disease pathology, uncovering new drug targets
Fierce Biotech
Mon, 04/13/20 - 09:41 pm
R&D
Alzheimer's disease
glucose metabolism
Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment
BioSpace
Sat, 04/11/20 - 10:59 pm
Biogen
patents
Alzheimer's disease
aducanumab
Creative Biolabs
Axon's Tau Vaccine Shows Promise in Phase II Alzheimer's Study
BioSpace
Fri, 04/3/20 - 06:34 pm
Axon Neurosciences
Alzheimer's disease
clinical trials
vaccines
Biogen sues over 'brazenly' copied aducanumab drug
Fierce Biotech
Thu, 03/19/20 - 11:10 am
Biogen
Creative Biolabs
Alzheimer's disease
aducanumab
Biogen Could Score a Major Win if Alzheimer's Drug Gets the Green Light
Motley Fool
Fri, 02/28/20 - 11:49 pm
Biogen
Alzheimer's disease
aducanumab
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
Will Wearables Be the New Way to Detect Early Signs of Alzheimer’s?
Xtalks
Fri, 02/14/20 - 04:59 pm
Alzheimer's disease
Alzheimer's Research UK
wearables
devices
VTV celebrates a double positive
EP Vantage
Wed, 02/12/20 - 10:29 am
vTv Therapeutics
Alzheimer's disease
diabetes
azeliragon
clinical trials
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Tue, 02/11/20 - 10:36 am
Biogen
Mylan
Alzheimer's disease
patents
Tecfidera
MS
multiple sclerosis
Vumerity
Lilly and Roche's antibodies fail late-phase Alzheimer's test
Fierce Biotech
Mon, 02/10/20 - 10:17 am
Eli Lilly
Roche
Alzheimer's disease
clinical trials
solanezumab
gantenerumab
Roche’s gantenerumab fails to meet primary endpoint in AD trial
Pharmaceutical Business Review
Mon, 02/10/20 - 10:08 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
Merck's Insomnia Drug Approved for Alzheimer's Patients
Motley Fool
Mon, 02/3/20 - 11:48 pm
Merck
FDA
Alzheimer's disease
Belsomra
insomnia
Preventive Alzheimer's trial data due within weeks, Lilly says
BioPharma Dive
Thu, 01/30/20 - 09:14 pm
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Newly Discovered Alzheimer's Gene Hints at Possible Breakthrough for the Disease
BioSpace
Thu, 01/23/20 - 12:08 pm
Alzheimer's disease
Case Western Reserve
aggregatin
2 Reasons to be Optimistic About Biogen’s Alzheimer’s Drug
Motley Fool
Tue, 01/21/20 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Novo Nordisk’s quiet entry into the year of Alzheimer’s
EP Vantage
Mon, 01/20/20 - 10:19 pm
Novo Nordisk
Victoza
Alzheimer's disease
I Have a Dream… Five Dreams for Biotech
BioSpace
Mon, 01/20/20 - 11:03 am
biotech
patients
Alzheimer's disease
ALS
HIV
cancer
drug pricing
JPM: Biotech, VC execs on where the industry should look beyond cancer
Fierce Biotech
Fri, 01/17/20 - 12:34 pm
oncology
cancer
Alzheimer's disease
diabetes
venture capital
JPMHC 2020
Analysts tip Biogen to file for aducanumab approval within weeks
Fierce Biotech
Thu, 01/16/20 - 10:10 am
Biogen
Alzheimer's disease
aducanumab
FDA
JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing
Fierce Pharma
Tue, 01/14/20 - 10:49 am
Biogen
Alzheimer's disease
drug pricing
aducanumab
JPMHC 2020

Pages